ES2729035T3 - Microesferas cristalinas y el proceso para fabricarlas - Google Patents
Microesferas cristalinas y el proceso para fabricarlas Download PDFInfo
- Publication number
- ES2729035T3 ES2729035T3 ES13781897T ES13781897T ES2729035T3 ES 2729035 T3 ES2729035 T3 ES 2729035T3 ES 13781897 T ES13781897 T ES 13781897T ES 13781897 T ES13781897 T ES 13781897T ES 2729035 T3 ES2729035 T3 ES 2729035T3
- Authority
- ES
- Spain
- Prior art keywords
- microspheres
- composition comprises
- microsphere
- approximately
- less
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000004005 microsphere Substances 0.000 title claims abstract description 978
- 238000000034 method Methods 0.000 title description 43
- 230000008569 process Effects 0.000 title description 26
- 238000004519 manufacturing process Methods 0.000 title description 18
- 239000000203 mixture Substances 0.000 claims abstract description 297
- 229920005862 polyol Polymers 0.000 claims abstract description 19
- 150000003077 polyols Chemical class 0.000 claims abstract description 18
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 116
- 239000000594 mannitol Substances 0.000 claims description 111
- 229930195725 Mannitol Natural products 0.000 claims description 107
- 235000010355 mannitol Nutrition 0.000 claims description 107
- 239000002245 particle Substances 0.000 claims description 100
- 239000000463 material Substances 0.000 claims description 73
- 239000008186 active pharmaceutical agent Substances 0.000 claims description 49
- 238000009826 distribution Methods 0.000 claims description 33
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 10
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 10
- 239000000600 sorbitol Substances 0.000 claims description 10
- 239000008194 pharmaceutical composition Substances 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 238000000576 coating method Methods 0.000 description 89
- 239000011248 coating agent Substances 0.000 description 76
- 239000011049 pearl Substances 0.000 description 67
- 239000011324 bead Substances 0.000 description 51
- 238000001179 sorption measurement Methods 0.000 description 38
- 239000011162 core material Substances 0.000 description 35
- 239000003826 tablet Substances 0.000 description 26
- 239000000843 powder Substances 0.000 description 23
- 239000000155 melt Substances 0.000 description 20
- 239000007921 spray Substances 0.000 description 20
- 239000010408 film Substances 0.000 description 19
- 239000007788 liquid Substances 0.000 description 17
- 239000010410 layer Substances 0.000 description 16
- 239000007787 solid Substances 0.000 description 16
- 239000005357 flat glass Substances 0.000 description 15
- 238000001878 scanning electron micrograph Methods 0.000 description 14
- 230000015572 biosynthetic process Effects 0.000 description 13
- 238000005755 formation reaction Methods 0.000 description 13
- 239000003795 chemical substances by application Substances 0.000 description 12
- 239000006185 dispersion Substances 0.000 description 12
- 239000011521 glass Substances 0.000 description 12
- 239000011148 porous material Substances 0.000 description 12
- 238000000926 separation method Methods 0.000 description 12
- 238000013517 stratification Methods 0.000 description 12
- 239000004386 Erythritol Substances 0.000 description 11
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 11
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 11
- 235000019414 erythritol Nutrition 0.000 description 11
- 229940009714 erythritol Drugs 0.000 description 11
- 239000000546 pharmaceutical excipient Substances 0.000 description 11
- 229920002472 Starch Polymers 0.000 description 10
- 239000004480 active ingredient Substances 0.000 description 10
- 238000001816 cooling Methods 0.000 description 10
- 239000008187 granular material Substances 0.000 description 10
- 230000033001 locomotion Effects 0.000 description 10
- 238000002844 melting Methods 0.000 description 10
- 230000008018 melting Effects 0.000 description 10
- 235000019698 starch Nutrition 0.000 description 10
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 9
- 238000007906 compression Methods 0.000 description 9
- 239000013078 crystal Substances 0.000 description 9
- 239000012530 fluid Substances 0.000 description 9
- 230000004927 fusion Effects 0.000 description 9
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 9
- 238000004626 scanning electron microscopy Methods 0.000 description 9
- 239000008107 starch Substances 0.000 description 9
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 description 8
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 8
- 239000011230 binding agent Substances 0.000 description 8
- 230000006835 compression Effects 0.000 description 8
- 238000009472 formulation Methods 0.000 description 8
- 239000000905 isomalt Substances 0.000 description 8
- 235000010439 isomalt Nutrition 0.000 description 8
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 description 8
- 239000000845 maltitol Substances 0.000 description 8
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 8
- 235000010449 maltitol Nutrition 0.000 description 8
- 229940035436 maltitol Drugs 0.000 description 8
- 238000005259 measurement Methods 0.000 description 8
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 8
- 230000008520 organization Effects 0.000 description 8
- 235000000346 sugar Nutrition 0.000 description 8
- 239000000811 xylitol Substances 0.000 description 8
- 235000010447 xylitol Nutrition 0.000 description 8
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 8
- 229960002675 xylitol Drugs 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 7
- 238000005469 granulation Methods 0.000 description 7
- 230000003179 granulation Effects 0.000 description 7
- 238000005192 partition Methods 0.000 description 7
- 238000000113 differential scanning calorimetry Methods 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 239000008108 microcrystalline cellulose Substances 0.000 description 6
- 229940016286 microcrystalline cellulose Drugs 0.000 description 6
- 239000003981 vehicle Substances 0.000 description 6
- 239000002775 capsule Substances 0.000 description 5
- 239000007910 chewable tablet Substances 0.000 description 5
- 238000001000 micrograph Methods 0.000 description 5
- 238000005204 segregation Methods 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 238000005054 agglomeration Methods 0.000 description 4
- 230000002776 aggregation Effects 0.000 description 4
- 235000010980 cellulose Nutrition 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 4
- 239000001913 cellulose Substances 0.000 description 4
- 239000011247 coating layer Substances 0.000 description 4
- 238000004090 dissolution Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 4
- 238000010191 image analysis Methods 0.000 description 4
- 239000002198 insoluble material Substances 0.000 description 4
- 238000011068 loading method Methods 0.000 description 4
- 239000004570 mortar (masonry) Substances 0.000 description 4
- 239000011164 primary particle Substances 0.000 description 4
- 238000005096 rolling process Methods 0.000 description 4
- 238000005507 spraying Methods 0.000 description 4
- 229910001220 stainless steel Inorganic materials 0.000 description 4
- 239000010935 stainless steel Substances 0.000 description 4
- 150000008163 sugars Chemical class 0.000 description 4
- 239000000654 additive Substances 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 239000007884 disintegrant Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- -1 fatty acid esters Chemical class 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 239000001307 helium Substances 0.000 description 3
- 229910052734 helium Inorganic materials 0.000 description 3
- 238000007373 indentation Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000000314 lubricant Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 239000008185 minitablet Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000012768 molten material Substances 0.000 description 3
- 238000013268 sustained release Methods 0.000 description 3
- 239000012730 sustained-release form Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 244000241235 Citrullus lanatus Species 0.000 description 2
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 description 2
- 244000024675 Eruca sativa Species 0.000 description 2
- 235000014755 Eruca sativa Nutrition 0.000 description 2
- 238000001159 Fisher's combined probability test Methods 0.000 description 2
- 239000002202 Polyethylene glycol Chemical class 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 239000008135 aqueous vehicle Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 239000007771 core particle Substances 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 229910001873 dinitrogen Inorganic materials 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000194 fatty acid Chemical class 0.000 description 2
- 229930195729 fatty acid Chemical class 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 239000007888 film coating Substances 0.000 description 2
- 238000009501 film coating Methods 0.000 description 2
- 239000010419 fine particle Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 238000005243 fluidization Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000003979 granulating agent Substances 0.000 description 2
- 235000015220 hamburgers Nutrition 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical class CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 210000003041 ligament Anatomy 0.000 description 2
- 239000007937 lozenge Substances 0.000 description 2
- 229940034008 mannitol / sorbitol Drugs 0.000 description 2
- 238000000386 microscopy Methods 0.000 description 2
- 230000006911 nucleation Effects 0.000 description 2
- 238000010899 nucleation Methods 0.000 description 2
- 238000003921 particle size analysis Methods 0.000 description 2
- 239000011236 particulate material Substances 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 239000004014 plasticizer Substances 0.000 description 2
- 229920001223 polyethylene glycol Chemical class 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 238000001812 pycnometry Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000004904 shortening Methods 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 150000005846 sugar alcohols Chemical class 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- ZSDSQXJSNMTJDA-UHFFFAOYSA-N trifluralin Chemical compound CCCN(CCC)C1=C([N+]([O-])=O)C=C(C(F)(F)F)C=C1[N+]([O-])=O ZSDSQXJSNMTJDA-UHFFFAOYSA-N 0.000 description 2
- 230000004584 weight gain Effects 0.000 description 2
- 235000019786 weight gain Nutrition 0.000 description 2
- 244000291564 Allium cepa Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 235000015866 Citrullus vulgaris var fistulosus Nutrition 0.000 description 1
- 244000016285 Citrullus vulgaris var. fistulosus Species 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- CXOFVDLJLONNDW-UHFFFAOYSA-N Phenytoin Chemical compound N1C(=O)NC(=O)C1(C=1C=CC=CC=1)C1=CC=CC=C1 CXOFVDLJLONNDW-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 238000002441 X-ray diffraction Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 230000000181 anti-adherent effect Effects 0.000 description 1
- 239000003911 antiadherent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- FFGPTBGBLSHEPO-UHFFFAOYSA-N carbamazepine Chemical compound C1=CC2=CC=CC=C2N(C(=O)N)C2=CC=CC=C21 FFGPTBGBLSHEPO-UHFFFAOYSA-N 0.000 description 1
- 229960000623 carbamazepine Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940068682 chewable tablet Drugs 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 238000002288 cocrystallisation Methods 0.000 description 1
- 239000012612 commercial material Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 239000012050 conventional carrier Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000005485 electric heating Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000005454 flavour additive Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 230000030136 gastric emptying Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 230000007773 growth pattern Effects 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 239000011344 liquid material Substances 0.000 description 1
- 239000006194 liquid suspension Substances 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 229960005015 local anesthetics Drugs 0.000 description 1
- 238000012792 lyophilization process Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000002687 nonaqueous vehicle Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical class CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Chemical class CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000002357 osmotic agent Substances 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 229960002036 phenytoin Drugs 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229940069328 povidone Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000012798 spherical particle Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000008117 stearic acid Chemical class 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 239000007916 tablet composition Substances 0.000 description 1
- 238000009475 tablet pressing Methods 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 238000002076 thermal analysis method Methods 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 210000003934 vacuole Anatomy 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 239000001993 wax Chemical class 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261638073P | 2012-04-25 | 2012-04-25 | |
| US201361783603P | 2013-03-14 | 2013-03-14 | |
| PCT/US2013/038257 WO2013163453A1 (en) | 2012-04-25 | 2013-04-25 | Crystalline microspheres and the process for manufacturing the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2729035T3 true ES2729035T3 (es) | 2019-10-29 |
Family
ID=49483900
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES13781897T Active ES2729035T3 (es) | 2012-04-25 | 2013-04-25 | Microesferas cristalinas y el proceso para fabricarlas |
Country Status (9)
| Country | Link |
|---|---|
| US (5) | US20150140097A1 (enExample) |
| EP (2) | EP3583935A1 (enExample) |
| JP (2) | JP6577865B2 (enExample) |
| BR (1) | BR112014026351B1 (enExample) |
| CA (1) | CA2871429C (enExample) |
| ES (1) | ES2729035T3 (enExample) |
| IN (1) | IN2014DN09416A (enExample) |
| MX (1) | MX359554B (enExample) |
| WO (1) | WO2013163453A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL219362A (en) | 2012-04-23 | 2017-04-30 | Verint Systems Ltd | A system and method for predicting threatened points of interest |
| CA2871429C (en) | 2012-04-25 | 2018-07-31 | Spi Pharma, Inc. | Crystalline microspheres and the process for manufacturing the same |
| US10560842B2 (en) | 2015-01-28 | 2020-02-11 | Verint Systems Ltd. | System and method for combined network-side and off-air monitoring of wireless networks |
| IL242354B (en) | 2015-10-29 | 2019-09-26 | Verint Systems Ltd | System and method for identifying genuine base stations that serve rogue base stations |
| IL245299B (en) | 2016-04-25 | 2021-05-31 | Verint Systems Ltd | A system and method for decoding communication transmitted in a wireless local communication network |
| JP2022523510A (ja) * | 2019-01-31 | 2022-04-25 | エレクトロフィ，インコーポレイテッド | 粒子形成及び形態構造 |
| US10639312B1 (en) * | 2019-12-06 | 2020-05-05 | Edenbridge Pharmaceuticals, LLC | Finished pharmaceutical dosage form of a methenamine salt such as methenamine mandelate |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4820627A (en) * | 1986-03-24 | 1989-04-11 | Em Diagnostic Systems, Inc. | Method of preparing particles suitable for tabletting into diagnostic reagents |
| JPH0192403A (ja) | 1987-09-30 | 1989-04-11 | Aprica Kassai Inc | 使い捨ておむつ |
| FR2670398B1 (fr) * | 1990-12-14 | 1995-02-17 | Roquette Freres | Composition pulverulente directement compressible et procede d'obtention. |
| US5573783A (en) | 1995-02-13 | 1996-11-12 | Nano Systems L.L.C. | Redispersible nanoparticulate film matrices with protective overcoats |
| US6548095B1 (en) | 1996-08-24 | 2003-04-15 | Südzucker Aktiengesellschaft | Sugar-free compressed products |
| US6235947B1 (en) * | 1997-04-14 | 2001-05-22 | Takeda Chemical Industries, Ltd. | D-mannitol and its preparation |
| US5780055A (en) | 1996-09-06 | 1998-07-14 | University Of Maryland, Baltimore | Cushioning beads and tablet comprising the same capable of forming a suspension |
| JPH1092403A (ja) | 1996-09-17 | 1998-04-10 | Sanyo Electric Co Ltd | 電池収納機構及びこれを具えた電子機器 |
| JP3447042B2 (ja) * | 1997-07-23 | 2003-09-16 | フロイント産業株式会社 | 単一物質球形粒の製造方法 |
| GB9716432D0 (en) * | 1997-08-05 | 1997-10-08 | Cerestar Holding Bv | Tableting of erythritol |
| JP2000128774A (ja) | 1998-10-26 | 2000-05-09 | Tanabe Seiyaku Co Ltd | 薬物を含有する球形微粒子の製法 |
| US6248363B1 (en) | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| WO2002035991A2 (en) * | 2000-10-30 | 2002-05-10 | The Board Of Regents, The University Of Texas System | Spherical particles produced by a hot-melt extrusion/spheronization process |
| US20030129250A1 (en) * | 2001-11-20 | 2003-07-10 | Advanced Inhalation Research Inc. | Particulate compositions for improving solubility of poorly soluble agents |
| US7118765B2 (en) | 2001-12-17 | 2006-10-10 | Spi Pharma, Inc. | Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms |
| ES2334991T3 (es) * | 2002-03-26 | 2010-03-18 | Teva Pharmaceutical Industries Ltd. | Microparticulas de farmaco. |
| GB0228826D0 (en) * | 2002-12-11 | 2003-01-15 | Okpala Joseph | Hair technology in creating particles with improved delivery capabilities |
| MXPA05008187A (es) * | 2003-01-29 | 2006-03-30 | Spi Polyols Inc | Composiciones de granulos de poliol y procesos de manufactura. |
| JP2007508240A (ja) * | 2003-07-22 | 2007-04-05 | バクスター・インターナショナル・インコーポレイテッド | 低分子量有機分子の小球状粒子ならびにその調製方法および使用方法 |
| US20070092562A1 (en) | 2003-10-28 | 2007-04-26 | Spi Pharma, Inc. | Product and process for increasing compactibility of carbohydrates |
| WO2005044193A2 (en) * | 2003-10-28 | 2005-05-19 | Spi Pharma, Inc. | Product and process for increasing compactibility of carbohydrates |
| EP1689368B1 (en) | 2003-12-04 | 2016-09-28 | Bend Research, Inc | Spray-congeal process using an extruder for preparing multiparticulate crystalline drug compositions |
| JP5634009B2 (ja) * | 2004-05-12 | 2014-12-03 | バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ | タンパク質を含み、そして高濃度のタンパク質で注射性能を示すミクロスフェア |
| WO2006058250A2 (en) | 2004-11-24 | 2006-06-01 | Spi Pharma, Inc. | Orally disintegrating compositions |
| WO2006109653A1 (ja) * | 2005-04-06 | 2006-10-19 | Sanyo Chemical Industries, Ltd. | 樹脂粒子および樹脂分散体 |
| JP2007217651A (ja) * | 2006-02-20 | 2007-08-30 | Daicel Chem Ind Ltd | 環状ポリオレフィン系樹脂の球状粒子およびその製造方法 |
| ES2358178T3 (es) | 2006-08-01 | 2011-05-06 | The Procter And Gamble Company | Partícula liberadora que contiene un agente beneficioso. |
| WO2008065504A1 (en) | 2006-11-30 | 2008-06-05 | Pfizer Products Inc. | Multiparticulates of spray-coated drug and polymer on a meltable core |
| WO2008094877A2 (en) | 2007-01-30 | 2008-08-07 | Drugtech Corporation | Compositions for oral delivery of pharmaceuticals |
| US8883307B2 (en) | 2007-05-28 | 2014-11-11 | Mitsubishi Shoji Foodtech Co., Ltd. | Spherical particle of crystalline mannitol |
| JP5258268B2 (ja) | 2007-11-19 | 2013-08-07 | フロイント産業株式会社 | 球形粒の製造方法 |
| JP5650532B2 (ja) * | 2008-08-18 | 2015-01-07 | 三菱商事フードテック株式会社 | 新規マンニトール打錠用賦形剤 |
| WO2010104563A2 (en) | 2009-03-09 | 2010-09-16 | Spi Pharma, Inc. | Highly compactable and durable direct compression excipients and excipient systems |
| BRPI1011412A8 (pt) * | 2009-05-08 | 2018-01-02 | Orexo Ab | composição para liberação sustentada de droga compreendendo aglutinante geopolimérico |
| JP2011157348A (ja) * | 2010-01-05 | 2011-08-18 | Fuji Chem Ind Co Ltd | 崩壊性高強度球状粒子組成物 |
| DE102010045479A1 (de) | 2010-09-16 | 2014-10-30 | Brace Capital Gmbh | Verfahren zur Mikroverkapselung, Herstellung von festen Formen mehrphasiger mischbarer und nichtmischbarer Materialien und Methode zur Herstellung vorgenannter Systeme |
| MX364560B (es) | 2010-09-20 | 2019-05-02 | Spi Pharma Inc Star | Proceso de microencapsulacion y producto. |
| CA2871429C (en) | 2012-04-25 | 2018-07-31 | Spi Pharma, Inc. | Crystalline microspheres and the process for manufacturing the same |
-
2013
- 2013-04-25 CA CA2871429A patent/CA2871429C/en active Active
- 2013-04-25 MX MX2014012805A patent/MX359554B/es active IP Right Grant
- 2013-04-25 WO PCT/US2013/038257 patent/WO2013163453A1/en not_active Ceased
- 2013-04-25 US US14/397,011 patent/US20150140097A1/en not_active Abandoned
- 2013-04-25 JP JP2015509147A patent/JP6577865B2/ja active Active
- 2013-04-25 ES ES13781897T patent/ES2729035T3/es active Active
- 2013-04-25 EP EP19163519.2A patent/EP3583935A1/en not_active Withdrawn
- 2013-04-25 EP EP13781897.7A patent/EP2841057B1/en active Active
- 2013-04-25 BR BR112014026351-5A patent/BR112014026351B1/pt active IP Right Grant
- 2013-04-25 IN IN9416DEN2014 patent/IN2014DN09416A/en unknown
- 2013-04-25 US US13/870,556 patent/US9089487B2/en active Active
-
2015
- 2015-07-27 US US14/809,362 patent/US10245232B2/en active Active
-
2019
- 2019-03-11 JP JP2019043904A patent/JP2019112438A/ja active Pending
- 2019-04-01 US US16/371,262 patent/US11278496B2/en active Active
-
2022
- 2022-02-08 US US17/666,608 patent/US12233163B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US9089487B2 (en) | 2015-07-28 |
| BR112014026351A2 (pt) | 2017-06-27 |
| EP2841057B1 (en) | 2019-03-20 |
| EP2841057A4 (en) | 2015-09-16 |
| US20220151932A1 (en) | 2022-05-19 |
| MX359554B (es) | 2018-10-02 |
| CA2871429A1 (en) | 2013-10-31 |
| IN2014DN09416A (enExample) | 2015-07-17 |
| JP2015514809A (ja) | 2015-05-21 |
| CA2871429C (en) | 2018-07-31 |
| EP2841057A1 (en) | 2015-03-04 |
| US12233163B2 (en) | 2025-02-25 |
| US10245232B2 (en) | 2019-04-02 |
| US11278496B2 (en) | 2022-03-22 |
| WO2013163453A1 (en) | 2013-10-31 |
| BR112014026351B1 (pt) | 2022-09-27 |
| JP6577865B2 (ja) | 2019-09-18 |
| US20150140097A1 (en) | 2015-05-21 |
| JP2019112438A (ja) | 2019-07-11 |
| US20190224126A1 (en) | 2019-07-25 |
| US20140099372A1 (en) | 2014-04-10 |
| EP3583935A1 (en) | 2019-12-25 |
| MX2014012805A (es) | 2015-01-22 |
| US20160015640A1 (en) | 2016-01-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2729035T3 (es) | Microesferas cristalinas y el proceso para fabricarlas | |
| ES2761407T3 (es) | Forma de dosificación rápidamente dispersable de topiramato | |
| ES2688889T3 (es) | Proceso de mezcla sin disolvente para el recubrimiento de ingredientes farmacéuticos | |
| US20150366802A1 (en) | Rapidly Dispersible Dosage Form of Oxcarbazepine | |
| Li et al. | A novel gastro-floating multiparticulate system for dipyridamole (DIP) based on a porous and low-density matrix core: In vitro and in vivo evaluation | |
| MXPA06011765A (es) | Farmacos de sabor enmascarado en multiparticulados que se rompen. | |
| ES2925801T3 (es) | Preparación farmacéutica que comprende 3-fluoro-4-[7-metoxi-3-metil-8-(1-metil-1H-pirazol-4-il)-2-oxo-2,3-dihidro-imidazo[4,5-c]quinolin-1-il]-benzonitrilo | |
| ES2266496T3 (es) | Procedimiento para la preparacion de comprimidos a partir de sustancias farmaceuticamente activas que presentan propiedades de compresion desfavorables con un liquido de granulacion que comprende la celulosa microcristalina. | |
| JP2025527357A (ja) | 味マスキングマイクロスフェア及びその製造プロセスと使用 | |
| Sinha et al. | Extrusion-spheronization: process variables and characterization | |
| Wen | Adsorption at solid surfaces: pharmaceutical applications | |
| CN114028577A (zh) | 一种二氧化硅丸芯及其制备方法 | |
| Dahiya et al. | Gastroretentive dosage forms: an approach to oral controlled drug delivery systems | |
| HK1214768B (en) | Rapidly dispersible dosage form of topiramate |